Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase
- PMID: 11248122
- PMCID: PMC30697
- DOI: 10.1073/pnas.051003698
Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase
Abstract
The effects of testosterone on early atherogenesis and the role of aromatase, an enzyme that converts testosterone to estrogens, were assessed in low density lipoprotein receptor-deficient male mice fed a Western diet. Castration of male mice increased the extent of fatty streak lesion formation in the aortic origin compared with testes-intact animals. Administration of anastrazole, a selective aromatase inhibitor, to testes-intact males increased lesion formation to the same extent as that observed with orchidectomized animals. Testosterone supplementation of orchidectomized animals reduced lesion formation when compared with orchidectomized animals receiving the placebo. This attenuating effect of testosterone was not observed when the animals were treated simultaneously with the aromatase inhibitor. The beneficial effects of testosterone on early atherogenesis were not explained by changes in lipid levels. Estradiol administration to orchidectomized males attenuated lesion formation to the same extent as testosterone administration. Aromatase was expressed in the aorta of these animals as assessed by reverse transcription-PCR and immunohistochemistry. These results indicate that testosterone attenuates early atherogenesis most likely by being converted to estrogens by the enzyme aromatase expressed in the vessel wall.
Figures



Similar articles
-
Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis.Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):4055-60. doi: 10.1073/pnas.052703199. Proc Natl Acad Sci U S A. 2002. PMID: 11904449 Free PMC article.
-
Brain aromatase is neuroprotective.J Neurobiol. 2001 Jun 15;47(4):318-29. doi: 10.1002/neu.1038. J Neurobiol. 2001. PMID: 11351342
-
Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha.Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1055-61. doi: 10.1161/01.ATV.0000130467.65290.d4. Epub 2004 Apr 29. Arterioscler Thromb Vasc Biol. 2004. PMID: 15117737
-
Effects of testosterone and its metabolites on aromatase-immunoreactive cells in the quail brain: relationship with the activation of male reproductive behavior.J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):185-200. doi: 10.1016/0960-0760(95)00236-7. J Steroid Biochem Mol Biol. 1996. PMID: 8603040 Review.
-
Estradiol in elderly men.Aging Male. 2002 Jun;5(2):98-102. Aging Male. 2002. PMID: 12198740 Review.
Cited by
-
Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer.Curr Oncol Rep. 2024 Mar;26(3):299-306. doi: 10.1007/s11912-024-01512-x. Epub 2024 Feb 20. Curr Oncol Rep. 2024. PMID: 38376624 Review.
-
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.Cell Rep Med. 2023 Sep 19;4(9):101152. doi: 10.1016/j.xcrm.2023.101152. Epub 2023 Aug 12. Cell Rep Med. 2023. PMID: 37572667 Free PMC article.
-
Association of serum testosterone with lipid abnormalities in patients with angiographically proven coronary artery disease.Indian J Endocrinol Metab. 2013 Nov;17(6):1061-5. doi: 10.4103/2230-8210.122624. Indian J Endocrinol Metab. 2013. PMID: 24381885 Free PMC article.
-
Changes in Cardiac Autonomic Modulation in Women with Breast Cancer Using Aromatase Inhibitors and the Relation with Biochemical Variables.Arq Bras Cardiol. 2019 May;112(5):555-563. doi: 10.5935/abc.20190036. Epub 2019 Feb 28. Arq Bras Cardiol. 2019. PMID: 30843932 Free PMC article.
-
Association Between Aromatase Inhibitors and Myocardial Infarction Morbidity in Women With Breast Cancer: A Meta-Analysis of Observational Studies.Cancer Control. 2022 Jan-Dec;29:10732748221132512. doi: 10.1177/10732748221132512. Cancer Control. 2022. PMID: 36346929 Free PMC article.
References
-
- Kannel W B, Hjortland M C, McNamara P M, Gordon T. Ann Intern Med. 1976;85:447–452. - PubMed
-
- Stampfer J M, Colditz G A. Prev Med. 1991;20:47–63. - PubMed
-
- Green A, Bain C. Ballieres Clin Endocrinol Metab. 1993;7:95–112. - PubMed
-
- Sullivan M L, Martinez C M, Gennis P, Gallagher E J. Prog Cardiovasc Dis. 1998;41:1–15. - PubMed
-
- Hayward C S, Kelly R P, Collins P. Cardiovasc Res. 2000;46:28–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases